EP0663819A4 - Ibuprofen-caffeine combinations. - Google Patents

Ibuprofen-caffeine combinations.

Info

Publication number
EP0663819A4
EP0663819A4 EP93922264A EP93922264A EP0663819A4 EP 0663819 A4 EP0663819 A4 EP 0663819A4 EP 93922264 A EP93922264 A EP 93922264A EP 93922264 A EP93922264 A EP 93922264A EP 0663819 A4 EP0663819 A4 EP 0663819A4
Authority
EP
European Patent Office
Prior art keywords
ibuprofen
caffeine combinations
caffeine
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93922264A
Other languages
German (de)
French (fr)
Other versions
EP0663819A1 (en
Inventor
Robert T Sims
William Slivka
Robert Mcmahon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Johnson and Johnson Consumer Inc
Original Assignee
Merck and Co Inc
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc, McNeil PPC Inc filed Critical Merck and Co Inc
Publication of EP0663819A1 publication Critical patent/EP0663819A1/en
Publication of EP0663819A4 publication Critical patent/EP0663819A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
EP93922264A 1992-09-29 1993-09-21 Ibuprofen-caffeine combinations. Withdrawn EP0663819A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95342392A 1992-09-29 1992-09-29
US953423 1992-09-29
PCT/US1993/008896 WO1994007471A1 (en) 1992-09-29 1993-09-21 Ibuprofen-caffeine combinations

Publications (2)

Publication Number Publication Date
EP0663819A1 EP0663819A1 (en) 1995-07-26
EP0663819A4 true EP0663819A4 (en) 1998-05-27

Family

ID=25493974

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93922264A Withdrawn EP0663819A4 (en) 1992-09-29 1993-09-21 Ibuprofen-caffeine combinations.

Country Status (6)

Country Link
EP (1) EP0663819A4 (en)
JP (1) JPH08501796A (en)
AU (1) AU5132893A (en)
CA (1) CA2144152A1 (en)
MX (1) MX9306005A (en)
WO (1) WO1994007471A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151740T1 (en) * 1992-12-02 1997-05-15 Knoll Ag METHOD FOR PRODUCING ESSENTIAL ENANTIOMERS OF PHENYLPROPIONIC ACIDS
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
JPH0987174A (en) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd Analgesic and anti-inflammatory composition
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
BR112017003425A2 (en) * 2014-08-28 2017-11-28 Sanofi Aventis De Mexico Sa De Cv pharmaceutical composition for the treatment of acute dental or mandibular pain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
WO1992005783A1 (en) * 1990-09-28 1992-04-16 Merck & Co., Inc. Ibuprofen-antihistamine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
WO1992005783A1 (en) * 1990-09-28 1992-04-16 Merck & Co., Inc. Ibuprofen-antihistamine combinations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9407471A1 *

Also Published As

Publication number Publication date
AU5132893A (en) 1994-04-26
WO1994007471A1 (en) 1994-04-14
JPH08501796A (en) 1996-02-27
MX9306005A (en) 1995-01-31
CA2144152A1 (en) 1994-04-14
EP0663819A1 (en) 1995-07-26

Similar Documents

Publication Publication Date Title
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (en) Auto-reclosers.
EP0655440A3 (en) 1-Aminoethylindoles.
EP0641704A3 (en) Monowheel travois.
EP0620222A3 (en) Tetrahydro-beta-carbolines.
EP0598412A3 (en) Skinprotection composition.
EP0633771A4 (en) Compounds.
ZA946728B (en) Tocopherois.
EP0620223A3 (en) Tetrahydro-pyrido-indole.
EP0572808A3 (en) Antiblocage-system.
DE59204008D1 (en) Trachealstent.
ZA926482B (en) Cyanophenylpyrroles.
EP0668864A4 (en) Substituted biphenylmethylimidazopyridines.
ZA927792B (en) Anti-alpha6-integrin-antibodies.
ZA929590B (en) Diphenylsulphides.
ZA937127B (en) Catch.
EP0599191A3 (en) Speed-governor-circuit.
EP0609763A3 (en) Ph-glasselectrode.
DE69205795D1 (en) Mesoprotheseunterlage.
EP0657193A3 (en) Skibrake.
EP0603840A3 (en) Pivot.
EP0592354A3 (en) Vacuum-centrifuge.
DE69203865D1 (en) Thermo-transferdrucksystem.
EP0641898A3 (en) Manholecover.
EP0663819A4 (en) Ibuprofen-caffeine combinations.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19980414

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19971001